R. Rossi

891 total citations · 1 hit paper
6 papers, 681 citations indexed

About

R. Rossi is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, R. Rossi has authored 6 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Immunology. Recurrent topics in R. Rossi's work include Acute Myeloid Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). R. Rossi is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). R. Rossi collaborates with scholars based in United States, Australia and Italy. R. Rossi's co-authors include Craig T. Jordan, SJ Szilvassy, GL Phillips, Barry Grimes, Todd E. Meyerrose, S. M. Luger, Steven Fischkoff, Kevin P. Callahan, Marlene Balys and Mohammad Minhajuddin and has published in prestigious journals such as Cell Reports, Leukemia and Experimental Hematology.

In The Last Decade

R. Rossi

6 papers receiving 670 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

2000 623 citations Craig T. Jordan, SJ Szilvassy et al. Leukemia profile →

Peers

R. Rossi

HEMAT

ONCOL

MB

IMMUN

GENET

Cyril Šálek Czechia

Françoise Mallet France

Mayumi Sugita United States

Grégory Ehx Belgium

Maurizio Affer United States

Yuji Shimura Japan

Sanjiv Modi United States

Kathryn J. Newhall United States

Bühring Hj Germany

Olga Gielen Belgium

Cyril Šálek Czechia

R. Rossi

201 ×0.6

HEMAT

275 ×0.9

ONCOL

243 ×0.9

MB

311 ×1.4

IMMUN

85 ×1.4

GENET

Citations per year, relative to R. Rossi R. Rossi (= 1×) peers Cyril Šálek

Countries citing papers authored by R. Rossi

Since Specialization

Citations

This map shows the geographic impact of R. Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Rossi more than expected).

Fields of papers citing papers by R. Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Rossi. The network helps show where R. Rossi may publish in the future.

Co-authorship network of co-authors of R. Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of R. Rossi. A scholar is included among the top collaborators of R. Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Rossi. R. Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Qian, Fenghua, Jiayan Zhou, Molly A. Hall, et al.. (2023). Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells. Cell Reports. 42(7). 112794–112794. 4 indexed citations

2.

Callahan, Kevin P., Mohammad Minhajuddin, Cheryl A. Corbett, et al.. (2014). Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity. Leukemia. 28(10). 1960–1968. 31 indexed citations

3.

Jordan, Craig T., SJ Szilvassy, Todd E. Meyerrose, et al.. (2000). The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 14(10). 1777–1784. 623 indexed citations breakdown →

4.

Micallef, Suzanne J., Robert G. Ramsay, Brenda Williams, et al.. (2000). The role of c-myb and BCL-2 in hematopoietic stem cell regulation. Experimental Hematology. 28(7). 68–68. 2 indexed citations

5.

Mezzasoma, Letizia, Ricardo M. Biondi, Celso Eduardo Benedetti, et al.. (1994). In vitro production of leukemia inhibitory factor (LIF) by Hep G2 hepatoblastoma cells.. PubMed. 7(4). 126–32. 4 indexed citations

6.

Rossi, R., et al.. (1989). Factors responsible for variable reported lineages of HL-60 cells induced to mature with butyric acid.. PubMed. 49(13). 3594–7. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact